Buscar
Congreso SOLACI
HomeCoronary diseaseAcute coronary syndromes

Acute coronary syndromes

Ver Categoría

Acute coronary syndromes

Multiple vs. Culprit vessel MI in Cardiogenic Shock: Anything New?

The Shock Trial, the one that set revascularization as the standard strategy to treat all STEMI and...
solaci -
Ver más
Acute coronary syndromes

Compare-Acute Sub-Study: Natural History of Non-Culprit Lesions in MI

The aim of this study was to determine the prognostic value of fractional flow reserve (FFR) of...
solaci -
Ver más
Acute coronary syndromes

Bleeding and Cardiogenic Shock: An “Unholy Alliance”?

Courtesy of Dr. Carlos Fava. Mortality in acute myocardial infarction (MI) with cardiogenic shock (CS) has been reduced over...
solaci -
Ver más
Acute coronary syndromes

Priorities in the Cath Lab to Escape COVID-19 Tsunami

The pandemic tsunami of COVID-19 has hit all cath lab services, especially those performing primary PCI.  Passively waiting...
solaci -
Ver más
Acute coronary syndromes

Covid-19 and Unaccounted Collateral Damage

Dr Metzler and collaborators carried out a retrospective search to find out the impact of the Covid-19...
solaci -
Ver más
Acute coronary syndromes

Temporary Emergency Guidelines for Infarction During the Pandemic

Several United States societies (the American Heart Association among them) have answered the question of many...
solaci -
Ver más
Acute coronary syndromes

Post-MI Colchicine: Cost-Effective with Good Results

Low colchicine doses reduce the risk of post-AMI ischemic events according to the COLCOT trial, originally presented...
solaci -
Ver más
Acute coronary syndromes

Cardiovascular Sequelae Associated with COVID-19

Myocardial injury, as defined by an increased troponin level, can occur due to both ischemic and nonischemic...
solaci -
Ver más

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Dr. Omar Tupayachi - 0
Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Dr. Omar Tupayachi - 0
Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Dr. Juan Manuel Pérez - 0
Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....

Noticias Institucionales

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad